293 related articles for article (PubMed ID: 18424862)
1. Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.
Katsaragakis S; Kapralou A; Markogiannakis H; Kofinas G; Theodoraki EM; Larentzakis A; Menenakos E; Theodorou D
Neth J Med; 2008 Apr; 66(4):154-9. PubMed ID: 18424862
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic preoperative levosimendan administration in heart failure patients undergoing elective non-cardiac surgery: a preliminary report.
Katsaragakis S; Kapralou A; Drimousis P; Markogiannakis H; Larentzakis A; Kofinas G; Misthos P; Filis K; Theodorou D
Hellenic J Cardiol; 2009; 50(3):185-92. PubMed ID: 19465359
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
4. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
[TBL] [Abstract][Full Text] [Related]
6. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A
J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
9. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.
Leppikangas H; Järvelä K; Sisto T; Maaranen P; Virtanen M; Lehto P; Karlsson S; Kööbi T; Lindgren L
Br J Anaesth; 2011 Mar; 106(3):298-304. PubMed ID: 21258075
[TBL] [Abstract][Full Text] [Related]
10. Value of IGF-I levels in the evaluation of response to treatment with levosimendan in patients with severe heart failure.
Işık S; Cetin M; Ciçekçioğlu H; Uçar O; Çetin ZG; Ozuğuz U; Bakır F; Berker D; Güler S
Anadolu Kardiyol Derg; 2011 Sep; 11(6):523-9. PubMed ID: 21821501
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
[TBL] [Abstract][Full Text] [Related]
12. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
[TBL] [Abstract][Full Text] [Related]
13. PREVENTION OF HEART FAILURE PATIENTS WITH DECREASED EJECTION FRACTION IN NON-CARDIAC SURGERY: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION?
Likhvantsev VV; Marchenko DN; Grebenshchikov OA; Ubasev YV; Zabelina TS; Timoshin SS; Skripkin YV; Ovezov AM; Lar'kov RN; Philippovskaya ZS; Sungurov VA
Anesteziol Reanimatol; 2016 Nov; 61(6):411-417. PubMed ID: 29894607
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
[TBL] [Abstract][Full Text] [Related]
15. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan for Hemodynamic Support after Cardiac Surgery.
Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
[TBL] [Abstract][Full Text] [Related]
18. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
Hou ZQ; Sun ZX; Su CY; Tan H; Zhong X; Hu B; Zhou Y; Shang DY
Cardiovasc Ther; 2013 Apr; 31(2):108-14. PubMed ID: 23490237
[TBL] [Abstract][Full Text] [Related]
19. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
